Neuros Medical
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
26800 Aliso Viejo Pkwy Ste 250, Aliso Vi...Phone Number
(440) 951-2565Website
www.neurosmedical.comRevenue
$17.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Neuros Medical
Neuros Medical, a neuromodulation company, has developed the Altius system for the treatment of chronic post-amputation pain (phantom limb pain and residual limb pain). Altius incorporates the Company's patented platform technology, High-Frequency Nerve Block. Neuros Medical's technology, originally invented by Drs. Kevin Kilgore and Niloy Bhadra of Case Western Reserve University, delivers a high-frequency electrical signal to sensory nerves in the peripheral nervous system to block the pain signal. The system consists of a nerve cuff electrode (also known as a lead) placed around a peripheral nerve, and an implantable pulse generator (IPG). Chronic pain is characterized as pain lasting more than 3 months in duration. Post-amputation pain includes both phantom limb and residual limb (or "stump") pain, and impacts millions Americans.Explore more
Neuros Medical Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuros Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Neuros Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Neuros Medical had a recent Job posting/layoffs
Earning: See what the market has to say on Neuros Medical recently announced quarterly report
Check out if Neuros Medical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Neuros Medical
Funding: Get notified immidiatlly once Neuros Medical has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Neuros Medical launches new products
Check if Neuros Medical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Neuros Medical
Compare insights from companies similar to Neuros Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neuros Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuros Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuros Medical.
Neuros Medical financials insights
Gather financial insights about Neuros Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Other Financing Round
$6M
2017
Other Financing Round
$20M
2020
Debt
$350K
2021
Other Financing Round
$35.8M
Series B
$38.5M
2023
Debt
$25M
2025
Series D
$56M
Private Equity
$56M
2026
Private Equity
$35M
Neuros Medical Tech Stack
A closer look at the technologies used by Neuros Medical
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Zach Stassen, Chief Financial Officer, has recently left the organization and now serves as Chief Financial Officer for Precision IO Group.
Executive Moves, Left Company
Person-Based
Partnership, Business Development, Finance, Financing & Debt
Funding
Funding
Funding
Funding
Neuros Medical News & Media
Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption
PHOENIX, March 10, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $35 million in growth capital to Neuros Medical, Inc., a MedTech company focused on alleviating chronic...Neuros Medical Announces First Commercial Implant of the Altius® Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
ALISO VIEJO, Calif., July 23, 2025 /PRNewswire/ -- In a major milestone for chronic post-amputation pain treatment, the first commercial patient in the U.S. has been successfully implanted with the FDA-approved Altius® System – marking the beginning of the company's mission to relieve...Neuros Medical Scores $56M Series D
ALISO VIEJO, CA, Neuros Medical, the maker of the Altius Direct Electrical Nerve Stimulation System, announced a $56 million Series D.EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to ... - PR Newswire
/PRNewswire/ -- EQT Life Sciences ("EQT") is pleased to announce that the LSP 7 fund and the EQT Health Economics strategy have co-led the USD 56 million...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuros Medical
Sign Up For FreeTo access detailed company insights
Neuros Medical, a neuromodulation company, has developed the Altius system for the treatment of chronic post-amputation pain (phantom limb pain and residual limb pain). Altius incorporates the Company's patented platform technology, High-Frequency Nerve Block. Neuros Medical's technology, originally invented by Drs. Kevin Kilgore and Niloy Bhadra o... Read More
